Haitao X. Zhao
No. 100 Kexue Avenue
Zhengzhou, 450001, China
Zhengzhou, 450001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 350 publications
mRNA cancer vaccines: delivery strategies, immune modulation, and clinical translation.
Journal: Frontiers in pharmacology
Published: April 10, 2026
The metabolic syndrome-cancer axis: global research trends and clinical landscapes.
Journal: Frontiers in endocrinology
Published: January 30, 2026
Efficacy and safety of pembrolizumab, lenvatinib, and reduced-dose gemcitabine/oxaliplatin as initial treatment for advanced biliary tract cancer: a multicenter, single-arm, prospective, phase II study.
Journal: Journal for immunotherapy of cancer
Published: January 28, 2026
Constructing a protein-protein interaction network for autoimmune liver diseases by integrating pQTL, rQTL, and mediation analyses.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: January 05, 2026
Occupational heat protection policies.
Journal: Bulletin of the World Health Organization
Published: January 02, 2026
Conversion surgery as a missing outcome in first-line immunotherapy trials for hepatocellular carcinoma.
Journal: Journal of hepatology
Published: December 21, 2025
Efficacy and safety of immune checkpoint inhibitors in patients with high microsatellite instability/mismatch repair-deficient advanced cholangiocarcinoma: A propensity score-matched study.
Journal: JHEP reports : innovation in hepatology
Published: December 11, 2025
Global trends and emerging frontiers of large language models in cancer research.
Journal: Digital health
Published: December 08, 2025
First-Line Pembrolizumab Plus Chemotherapy for Advanced Biliary Tract Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-966 Study.
Journal: Advances in therapy
Published: December 04, 2025
Effectiveness and conversion outcomes of immune checkpoint inhibitors combined with lenvatinib and GEMOX chemotherapy as first-line treatment for advanced gallbladder cancer: A multicenter study.
Journal: Chinese medical journal
Published: December 02, 2025
Real-world outcomes of first-line immunotherapy and subsequent systemic therapies in pleural mesothelioma: a multicenter study in China.
Journal: Translational lung cancer research
Published: November 25, 2025
Patient-Derived 3D-Bioprinted Intrahepatic Cholangiocarcinoma Models Recapitulate Tumor Autologous Traits and Predict Personalized Adjuvant Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 02, 2025
Last Updated: 09/26/2026